Barei F, Le Pen C, Simoens S. From generic to biosimilar drugs: why take an innovative pace?. Farmeconomia. Health Economics and Therapeutic Pathways. 2012;13(3S):21-27. https://doi.org/10.7175/fe.v13i3S.328